Business Standard

Wednesday, January 08, 2025 | 04:48 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Rossari Biotech receives three times the demand of shares on offer in IPO

On Tuesday, the IPO garnered bids for 24.3 million shares as against 8.17 million available

IPO
Premium

Axis Capital and ICICI Securities are the investment banks handling the issue. Illustration: Ajay Mohanty

Sundar Sethuraman Thiruvananthapuram
Rossari Biotech has received three times the demand of shares on offer in its initial public offering (IPO), which closes on Wednesday. 

On Tuesday, the IPO garnered bids for 24.3 million shares, as against 8.17 million available. 

The price band for the IPO is Rs 423-425 per share. At the top end, the IPO size works out to nearly Rs 500 crore and implies a post-IPO market cap of Rs 2,207 crore. 

Axis Capital and ICICI Securities are the investment banks handling the issue.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in